Patient information: uses, side effects, how to take - Succinylcholine
INSTRUCTIONS FOR USE
CAUTION: Assure that the needle or Needleless Luer Access Device (NLAD) is securely attached before beginning the injection. Visually inspect the syringe-needle or syringe-NLAD connection before and during drug administration.
Figure 1: Outer Packaging and Prefilled Syringe

Succinylcholine Chloride Injection may be administered intravenously or intramuscularly.
Inspect the outer packaging (flow wrap) and the syringe label by verifying:
Plastic overwrap integrity
Drug name
Drug strength
Fill volume
Route of administration
Expiration date to be sure that the drug has not expired
Sterile field applicability
Do not use if package has been damaged
Open the outer packaging and remove the syringe from the outer packaging. Do not pop syringe through. (See Figure 2)
Figure 2

Perform visual inspection on the syringe by verifying:
Absence of syringe damage
Absence of external particles
Absence of internal particles
Proper drug color
Push plunger rod slightly while tip cap is still on to break the stopper loose.
Remove the tip cap by twisting it off (Figure 3).

Discard the tip cap.
Expel air bubble(s).
Connect the syringe to an appropriate injection connection depending on the route of administration.
Before injection, ensure that the syringe is securely attached to the needle or NLAD.
Depress plunger rod to deliver the required dose of medication. Ensure that pressure is maintained on the plunger rod during the entire administration. Waste residual medication per institutional policy.
Remove syringe from NLAD (if applicable) and discard into appropriate receptacle. When needle is connected to the syringe, to prevent needle-stick injuries, do not recap needles.
NOTES:
All steps must be performed sequentially.
Do not autoclave syringe.
Do not use this product on a sterile field.
Do not introduce any other fluid into the syringe at any time.
Do not dilute for IV push.
This product is for single dose only, discard unused portion.
For more information concerning this drug, please call Fresenius Kabi USA, LLC at 1-800-551-7176.
To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
